Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01656616

Enrollment

Registered

2012-08-03

Start date

2012-08-01

Completion date

2012-08-01

Last updated

2017-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cyanide Poisoning

Keywords

Pharmacoeconomics, Cost effectiveness, Cyanide, Fire, Emergency Medical Services, Smoke Inhalation

Brief summary

The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.

Interventions

DRUGCyanide antidote administration

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Included in Maine EMS database * House Fire Victim * Poisoning

Exclusion criteria

* No potential cyanide exposure * Incomplete data available

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026